Annual productivity costs due to cervical cancer mortality in the United States

Women's Health Issues

Volumn 16, Issue 5, 2006, Pages 236-242

  Insinga, Ralph P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; COST OF ILLNESS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; PROBABILITY; PRODUCTIVITY; UNITED STATES; UTERINE CERVIX CANCER; WOMEN'S HEALTH; WORK;

ADULT; AGED; COST OF ILLNESS; EMPLOYMENT; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICES; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; UNITED STATES; WOMEN'S HEALTH; WOMEN, WORKING;

EID: 33750010916     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2006.06.005     Document Type: Article

References (52)

1. Andersen B.L., Anderson B., and deProsse C. Controlled prospective longitudinal study of women with cancer: II. Psychological outcomes. Journal of Consulting and Clinical Psychology 57 (1989) 692-697
2. Bell F.C., and Miller M.L. Life tables for the United States Social Security area, 1900-2100 (2002), Social Security Administration, Baltimore, MD
3. Brown M.L., and Fintor L. The economic burden of cancer. In: Greenwald, Kramer P., and Weed B.S. (Eds). D.L. Cancer prevention and control (1995), Marcel-Dekker, New York
4. Bureau of the Census. Statistical abstract of the United States 1946 (1946), U.S. Government Printing Office, Washington, D.C
5. Bureau of the Census. Vital statistics of the United States 1946: Part I (1946), U.S. Government Printing Office, Washington, D.C
6. Bureau of the Census. Statistical abstract of the United States 1935-1982 (2005), U.S. Government Printing Office, Washington, D.C
7. Bureau of Economic Analysis. Current dollar and "real" gross domestic product, 1929-2005 (2006), Author, Washington, D.C
8. Bureau of Labor Statistics and Bureau of the Census. Current population survey (2001), Author, Washington D.C
9. Bureau of Labor Statistics. Comparison of average hourly earnings, not seasonally adjusted, before and after the March 2005 benchmark (2005). http://www.bls.gov/ces/#analytical Available: www.bls.gov/ces/#analytical. Accessed July 1, 2005.
10. Bureau of Labor Statistics. Employment-population ratio, women. Current population survey (2005). http://www.bls.gov/cps/#data Available: www.bls.gov/cps/#data. Accessed September 23, 2005.
11. Cates Jr. W., and American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sexually Transmitted Diseases 26 (1999) S2-S7
12. Census Bureau. Annual estimates of the population by sex and 5-year age groups for the United States: April 1, 2000 to July 1, 2003 (NC-EST2003-01) (2005). http://www.census.gov Available: www.census.gov. Accessed May 25, 2005.
13. Census Bureau. Connecticut QuickFacts (2005). http://quickfacts.census.gov Available: http://quickfacts.census.gov. Accessed May 24, 2005.
14. Census Bureau. Monthly postcensal resident population, by single year of age, sex, race and Hispanic origin, 1990-1999 (2005), Author, Washington, D.C
15. Census Bureau. Quarterly population estimates, 1980-1990 (2005), Author, Washington, D.C
16. Census Bureau. Sex by single years of age, 2000 (2005), Author, Washington, D.C
17. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: A strategy for the 21st century. Overview of the updated CDC plan. MMWR Recommended Reports 47 (1998) 1-14
18. Centers for Disease Control and Prevention/National Center for Health Statistics. Deaths from each cause, by 5-year age groups, race, and sex: United States, 1994-2000 (2000), National Vital Statistics System, Mortality, Hyattsville, MD
19. Centers for Disease Control and Prevention/National Center for Health Statistics. Deaths from each cause, by 5-year age groups, race, and sex: United States, 2000 (2000), National Vital Statistics System, Mortality, Hyattsville, MD
20. Chesson H.W., Blandford J.M., Gift T.L., Tao G., and Irwin K.L. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspectives on Sexual and Reproductive Health 36 (2004) 11-19
21. Das G.R., and Guest J.F. Annual cost of bipolar disorder to UK society. British Journal of Psychiatry 180 (2002) 227-233
22. Devesa S.S., Silverman D.T., Young Jr. J.L., Pollack E.S., Brown C.C., Horm J.W., et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. Journal of the National Cancer Institute 79 (1987) 701-770
23. Eng T.R., and Butler W.T. The hidden epidemic: Confronting sexually transmitted diseases (1997), National Academy Press, Institute of Medicine, Washington, D.C
24. Food and Drug Administration (FDA). FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus: rapid approval marks major advancement in public health. FDA News P06-77 (2006) (June 8)
25. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
26. Gross C.P., Anderson G.F., and Powe N.R. The relation between funding by the National Institutes of Health and the burden of disease. New England Journal of Medicine 340 (1999) 1881-1887
27. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
28. Hirth R.A., Chernew M.E., Miller E., Fendrick A.M., and Weissert W.G. Willingness to pay for a quality-adjusted life year: in search of a standard. Medical Decision Making 20 (2000) 332-342
29. Insinga R.P., Dasbach E.J., and Elbasha E.H. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: Analytic framework and review of the literature. Pharmacoeconomics 23 (2005) 1107-1122
30. Insinga R.P., Glass A.G., and Rush B.B. Pap screening in a U.S. health plan. Cancer Epidemiology Biomarkers and Prevention 13 (2004) 355-360
31. Insinga R.P., Glass A.G., and Rush B.B. The health care costs of cervical human papillomavirus-related disease. American Journal of Obstetrics and Gynecology 191 (2004) 114-120
32. Janerich D.T., Hadjimichael O., Schwartz P.E., Lowell D.M., Meigs J.W., Merino M.J., et al. The screening histories of women with invasive cervical cancer, Connecticut. American Journal of Public Health 85 (1995) 791-794
33. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA: A Cancer Journal for Clinicians 55 (2005) 10-30
34. Johansson P.O. Is there a meaningful definition of the value of a statistical life?. Journal of Health Economics 20 (2001) 131-139
35. Karnon J., Peters J., Platt J., Chilcott J., McGoogan E., and Brewer N. Liquid-based cytology in cervical screening: An updated rapid and systematic review and economic analysis. Health Technology Assessment 8 (2004) iii, 1-iii, 78.
36. Kulasingam S.L., Hughes J.P., Kiviat N.B., Mao C., Weiss N.S., Kuypers J.M., et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of referral. Journal of the American Medical Association 288 (2002) 1749-1757
37. Laskey P.W., Meigs J.W., and Flannery J.T. Uterine cervical carcinoma in Connecticut, 1935-1973: Evidence for 2 classes of invasive disease. Journal of the National Cancer Institute 57 (1976) 1037-1043
38. Leyden W.A., Manos M.M., Geiger A.M., Weinmann S., Mouchawar J., Bischoff K., et al. Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. Journal of the National Cancer Institute 97 (2005) 675-683
39. Max W., Rice D.P., Sung H.Y., and Michel M. Valuing human life: Estimating the present value of lifetime earnings, 2000 (2004), Center for Tobacco Control Research and Education, 195 Economic Studies and Related Methods, University of California-San Francisco, San Francisco
40. Max W., Rice D.P., Sung H.Y., Michel M., Breuer W., and Zhang X. The economic burden of gynecologic cancers in California, 1998. Gynecologic Oncology 88 (2003) 96-103
41. Myers E.R., McCrory D.C., Subramanian S., McCall N., Nanda K., Datta S., et al. Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening. Obstetrics and Gynecology 96 (2000) 645-652
42. National Center For Health Statistics. Vital statistics of the United States, 1946-1959 (2005), Author, Hyattsville, MD
43. National Center For Health Statistics. Vital statistics of the United States, 1946-1993 (2005), Author, Hyattsville, MD
44. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 55 (2005) 74-108
45. Percy C.L., Horm J.W., Young Jr. J.L., and Asire A.J. Uterine cancers of unspecified origin-A reassessment. Public Health Reports 98 (1983) 176-180
46. Rice D.P. Cost of illness studies: What is good about them?. Injury Prevention 6 (2000) 177-179
47. Ries L., Eisner M., Kosary C., Hankey B.F., Miller B., Mariotto A., et al. SEER cancer statistics review, 1975-2000 (2003), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2000/ Available: http://seer.cancer.gov/csr/1975_2000/. Accessed June 15, 2005.
48. Ries L., Eisner M., Kosary C., Hankey B.F., Miller B., Mariotto A., et al. SEER cancer statistics review, 1975-2002 (2005), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2002/ Available: http://seer.cancer.gov/csr/1975_2002/. Accessed June 15, 2005.
49. Rolnick S., LaFerla J.J., Wehrle D., Trygstad E., and Okagaki T. Pap smear screening in a health maintenance organization: 1986-1990. Preventive Medicine 25 (1996) 156-161
50. Sung H.Y., Kearney K.A., Miller M., Kinney W., Sawaya G.F., and Hiatt R.A. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88 (2000) 2283-2289
51. Swan J., Breen N., Coates R.J., Rimer B.K., and Lee N.C. Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer 97 (2003) 1528-1540
52. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncology 6 (2005) 271-278